Close Menu

NEW YORK – OraSure Technologies reported after the close of the market on Wednesday that its third quarter revenues fell 22 percent year over year as overall product revenues declined 19 percent.

The firm also announced it will acquire Diversigen, a Houston-based microbiome and metagenomics consulting, sequencing, and data analysis service provider, for a cash purchase price of $12.0 million and the potential for an additional earn-out payment tied to revenue performance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.